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Abstract  
Background: The first study on quality of life (QoL) in patients with congenital heart disease 
was published 40 years ago. Since then, the number of QoL articles on these patients has 
grown exponentially. We conducted a systematic literature review of all empirical studies on 
QoL in patients with congenital heart disease published since 1974, with the aim of 
determining the range of conceptual and methodological rigor of studies and identifying 
temporal trends in these parameters.  
Methods: PubMed, Embase, and Cinahl were searched for empirical studies addressing QoL 
in children, adolescents, or adults with congenital heart disease, published between January 1, 
1974, and December 31, 2014. We applied 10 review criteria that were previously developed 
by Gill and Feinstein in 1994 and further refined by Moons et al. in 2004. Overall, 234 
articles were reviewed.  
Results: We found slight but non-significant temporal improvements in conceptual and 
methodological rigor and in use of assessment methods. This indicates a trend toward a more 
professional and exacting approach in QoL assessments. However, the majority of articles still 
had substantial conceptual and methodological deficits. Furthermore, we observed that 
citation of the publications of Gill and Feinstein and Moons et al. in published QoL research 
is associated with higher quality scores, suggesting that these articles have a positive impact 
on conceptual and methodological caliber. 
Conclusion: Despite 40 years of QoL research in this field, this review shows that major 
weaknesses in methodological rigor remain highly prevalent, which may make QoL studies 
inconclusive. 
 
Key Words: Quality of Life; Review; Heart Defect, Congenital; Adolescent; Health Services 
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1. Introduction 
In 1974, Dr. Charlotte Ferencz published the first report on quality of life (QoL) in individuals 
with congenital heart disease [1]. Since then, a plethora of QoL studies have been published. 
The main driving force for investigating QoL in individuals with congenital heart disease is 
decreasing mortality and morbidity, which has resulted in prolonged life expectancy for these 
patients [2, 3]. Clinicians and researchers have been intrigued by the question of how do the 
lives of patients with a congenital heart defect “look like,” and whether the heart defect has an 
impact on QoL.  
QoL, however, is an equivocal construct [4-6]. There is no uniform definition for 
QoL, which yields a conceptual haziness [5]. This, in turn, results in inaccurate measurements 
of “true” QoL and in inconclusive study findings. To direct more attention to this 
phenomenon, in 1994 Gill and Feinstein evaluated the quality of existing QoL research [4]. 
They concluded that a large majority of QoL studies had conceptual limitations, hampering 
the validity of the study findings [4]. The Gill and Feinstein review is a landmark article, 
having been cited more than 1200 times to date (ISI Web of Science; accessed 03/19/2015). 
Ten years later, Moons and coworkers [7] adopted the Gill and Feinstein 
methodology in evaluating studies of congenital heart disease. These investigators found that 
QoL studies in congenital heart disease also were lacking conceptual and methodological 
rigor, even more so than QoL studies in the general medical literature [4, 7]. It was striking 
that most researchers did not apply the same rigor to QoL studies as they did to defining and 
operationalizing outcomes in the area of morbidity and mortality. Indeed, successful research 
requires a rigorous scientific approach, in which the concepts used are properly defined and 
accurately documented. The methodologies applied and definitions used need to be described 
appropriately to allow for correct interpretation of findings and possible translation into 
practice. 
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It may be assumed, or hoped, that the articles of Gill and Feinstein [4] and Moons et 
al. [7] have since stimulated researchers to conduct and report their QoL studies more 
accurately. Hence, one would expect to observe a temporal improvement in the caliber of QoL 
studies, which might be a reasonable indicator of the influence of these two seminal 
publications. Therefore, the aims of this review were (i) to provide a description of research 
on QoL in congenital heart disease since the first publication from this field 40 years ago, and 
(ii) to determine whether temporal trends have emerged in conceptual and methodological 
rigor of QoL studies. 
 
2. Methods 
2.1 Search strategy 
We performed a systematic literature search in PubMed, Embase, and Cinahl, including all 
empirical studies addressing QoL in children, adolescents, or adults with congenital heart 
disease. The search epoch was inclusive of January 1, 1974, through December 31, 2014. The 
actual search was conducted January 1, 2015. Articles on primary studies were eligible for 
inclusion, if they were available online (e-pub ahead of print) or in print. The search strings 
we employed in searching the three databases are detailed in Appendix 1 (Electronic 
Supplemental Material). To omit publications that were inappropriate for inclusion, a 
hierarchy of exclusion criteria was developed and used during the screening of the abstracts 
(Appendix 2: Electronic Supplemental Material). 
 
2.2 Review criteria  
To appraise the conceptual and methodological rigor of QoL studies in congenital heart 
disease, we applied the review criteria that were previously developed by Gill and Feinstein 
[4]. They developed 10 criteria to evaluate the caliber of QoL articles. These criteria were 
based on the following definition of QoL: “Rather than being a description of patients’ health 
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status, QoL is a reflection of the way that patients perceive and react to their health status 
and to other, nonmedical aspects of their lives” [4]. The operationalization of the criteria was 
further refined by Moons et al. [7]. These criteria are extensively described in Appendix 3 
(Electronic Supplemental Material). 
 
2.3 Data selection process 
A flow chart of the search and selection procedure is shown in Appendix 2 (Electronic 
Supplemental Material). Database searches resulted in 1002 records. After removing 
duplicates, the 769 remaining articles were independently screened for eligibility by both 
authors. For references in which there was no agreement between the two reviewers about 
exclusion or about the reasons for exclusion, meetings were held to reach consensus. After 
these consensus meetings, 535 records were excluded (Appendix 2).  
Of the 234 included articles, full-text papers were independently reviewed and scored 
by the two authors using the 10 predefined criteria. Also here, consensus meetings were held 
to arrive at the final ratings of each individual article.  
 
2.4 Data synthesis and analyses 
Variables such as country where the study was conducted, age group, heart defect, sample 
size, and assessment tool/instrument were registered. The number of articles fulfilling each 
criterion was counted, and the percentage was calculated. To indicate how well individual 
articles performed with respect to all criteria, a summary score was calculated by summing 
the number of criteria an article fulfilled and dividing this sum by the number of criteria for 
which the article was eligible to be evaluated. The resulting value was then multiplied by 100. 
Hence, the main outcome measure was a summary score ranging from 0 (for articles 
complying with none of the criteria) to 100 (for articles complying with all criteria).  
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To investigate temporal trends in conceptual and methodological rigor since the 
publication of the first QoL article in congenital heart disease in 1974, the entire time period 
up to 2014 was divided into three epochs, using the publication years of Gill and Feinstein [4] 
and Moons et al. [7] as cutoffs between the epochs. The first period (1974-1994) is the epoch 
before the Gill and Feinstein review [4]. The second period (1995-2004) is the epoch after the 
Gill and Feinstein review [4], but before the publication of the Moons et al. article [7]. The 
third period (2005-2014) is the epoch after the Moons et al. publication [7]. For each period, 
we calculated the mean and median summary scores for each article. A one-way ANOVA was 
computed to investigate whether the mean summary scores for the three time periods were 
significantly different. A Chi-square test was performed on the proportion of studies 
complying with each individual criterion, over the three periods. To determine whether the 
publications of Gill and Feinstein [4] and Moons et al. [7] influenced the quality of the 
articles, we computed a Mann Whitney U test to compare the median scores before and after 
the respective publications. All tests were two-sided, and P<0.05 was used as the cutoff for 
statistical significance.  
 
3. Results 
3.1 Description of quality of life publications from 1974 to 2014  
To date, 234 empirical studies addressing QoL in patients with congenital heart disease have 
been published. The number of articles grew exponentially, starting with 1-2 articles per year 
in the first 20 years up to almost 35 articles during 2014 (Figure 1). Most studies included 
patients with a mix of different diagnoses and complexities (n=106 articles; 45.3%). Of the 
studies that included patients with a specific diagnosis, most were on patients with 
transposition of the great arteries (n=26; 11.1%); single ventricle physiology (n=25; 10.7%); 
or Fallot/double outlet right ventricle (n=20; 8.5%) (Figure 2). Forty-five studies investigated 
children aged 0-9 years (19.2%); 12 studies included adolescents aged 10-18 years (5.1%); 
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104 studies included adult patients >19 years (44.4%); and 73 studies included patients of 
different age groups (31.2%). The majority of the studies were performed in the United States 
(n=52; 22.2%); followed by the Netherlands (n=37; 15.8%); Germany (n=31; 13.2%); United 
Kingdom (n=15; 6.4%); and Belgium (n=13; 5.6%) (Appendix 4: Electronic Supplemental 
Material). The most commonly used assessment was the Short form-36 (SF-36) (n=62; 
26.5%), followed by the Pediatric Quality of Life inventory (PedsQL) (n=25; 10.7%). 
 
3.2 Temporal trends in conceptual and methodological rigor 
For all studies published from 1974 to 2014, the mean summary score was 15.2 (standard 
deviation: 22.1) and the median score was 0 (interquartile range: 0-25). Over the three distinct 
periods, a slight increase of the mean score was observed (Figure 3). This was because in 
2005-2014, 15.7% of the studies had a summary score of 50 or higher compared to 5.5% of 
the studies in 1995-2004 and 0% of the studies in 1974-1994. The increase in mean score was, 
however, not statistically significant (F=2.267; p=0.106). The median summary score 
increased in the second period (1995-2004) but dropped again to zero during the third period 
(2005-2014) (Figure 3).  
 
Over the three time periods, a statistically significant increase was observed for 
criterion 1 (providing a definition), criterion 3 (providing reason for instrument), and criterion 
4 (calculating index score) (Table 1). Still, only 23-34% of the studies fulfilled these four 
criteria today. Criteria 5-10 were seldom fulfilled. Indeed, in only a few studies were patients 
asked to give their own global rating for QoL (criterion 5), was overall QoL distinguished 
from health-related QoL (criterion 6), were patients invited to supplement the items that they 
considered to be relevant for their QoL (criterion 7), or were patients allowed to indicate 
which items were personally important to them (criterion 9). The two studies that fulfilled 
PLEASE, INSERT FIGURES 1 AND 2 ABOUT HERE 
PLEASE, INSERT FIGURE 3 ABOUT HERE 
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criteria 7 and 9, however, included this score in the final ratings of QoL, resulting in a 100% 
score. Overall, the entire body of studies in congenital heart disease we evaluated performed 
worse than the studies included in the Gill and Feinstein review (Table 1). The scoring for 
each individual article reviewed, is presented in Appendix 5 (Electronic Supplemental 
Material).
 
In addition to the review criteria applied, we observed that in 1974-1994, 8 of 13 
articles (61.5%) did not describe QoL in the methods or results section, but merely mentioned 
it in the abstract or discussion. This proportion decreased to 26 of 55 articles (47.3%) in 1995-
2004; and further decreased to 19 of 166 articles (11.4%) in 2005-2014. 
In order to determine whether the publications of Gill and Feinstein [4] and Moons et 
al. [7] may have had an impact on improving the conceptual and methodological rigor of QoL 
studies, we compared the scores of studies that cited or did not cite these respective articles. 
Five of the 221 articles (2.3%) that were published in 1995 or later cited the Gill and Feinstein 
publication, and 18 of 166 articles (10.8%) that were published in 2005 or later cited the 
Moons et al. paper. The articles that cited Gill and Feinstein [4] had a significantly higher 
median score (80; interquartile range: 43.75-90) than those that did not cite this paper (0; 
interquartile range: 0-25) (U=64.5; p<0.001). The articles that cited the Moons et al. review 
[7] also showed a significantly higher median score (37.5; interquartile range: 9.38-62.5) than 
those that did not cite it (0; interquartile range: 0-25) (U=719.5; p=0.001). 
 
3.3 Temporal trends in measurement methods 
During the first period (1974-1994), researchers predominantly used surrogate or proxy 
measures to assess QoL, such as employment status (38.5%); New York Heart Association 
(NYHA) classification (23.1%); educational level (23.1%); or symptoms (23.1%) (Table 2). 
PLEASE, INSERT TABLE 1 ABOUT HERE 
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In 15.4% of the articles, the assessment method was not reported. In the second period (1995-
2004), there was a trend toward the use of more comprehensive and dedicated instruments. 
Nonetheless, the NYHA functional class was still the most common measure (20%). The 
Medical Outcome Study SF-36 and the Congenital Heart Disease TNO/AZL Adult Quality of 
Life (CHD-TAAQOL) instruments were used in 9.1% of the studies. Still, in 18.2% of the 
articles, the assessment was not reported (Table 2). During the third period (2005-2014), we 
observed a dramatic change in assessment method used. The top 10 most frequently used 
assessment methods comprised only specific and dedicated QoL tools. The instruments used 
most frequently during this period were the SF-36 (34.3%), the PedsQL (15.1%), and the 
linear analogue scale (8.4%). The initially used surrogates, such as NYHA class, employment, 
or educational status, were not as commonly used in the third period (2005-2014). Another 
positive effect was a reduction in the percentage of studies that failed to specify how QoL was 
measured (3.6%) (Table 2).  
 
4. Discussion 
Over the past decades, QoL research has grown exponentially, both in the general biomedical 
field [5], and more specifically, in the field of congenital heart disease research. In the latter, 
QoL research is particularly important because it can be viewed as an indicator of the success 
of cardiac surgery and medical management of cardiac anomalies over the past half century. 
Findings of QoL research are most of all informative for afflicted patients or parents, when 
they have questions about future prospects with regard to their life course. For instance, 
parents of a newborn child with congenital heart disease want to know more about future 
consequences in daily life and QoL aspects. Furthermore, after prenatal diagnosis, future 
parents question the future QoL of their unborn child. Hence, QoL research provides guidance 
to health-care professionals in their medical decision making and when counseling patients 
PLEASE, INSERT TABLE 2 ABOUT HERE 
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and parents. Obviously, then, this counsel should be based on the most accurate and current 
data [8]. In this respect, it is extremely important that clinicians be able to rely on QoL data 
that is conceptually and methodologically sound.  
In the present review, we observed temporal improvements in the conceptual and 
methodological rigor in QoL studies focusing on patients with congenital heart disease. This 
is mainly because more articles with higher scores have been published over the past 10 years. 
Despite this upward trend, the majority of articles still have a low quality score. Indeed, 
during 2005-2014, 52.4% still failed to meet any of the quality criteria. Criteria that were 
fulfilled most frequently were “giving a definition of QoL” (criterion 1); “stating the domains 
of QoL to be measured” (criterion 2); “giving a reason for choosing the instruments they 
used” (criterion 3); and “aggregating the results from multiple items, domains, or instruments 
into a single composite score for QoL” (criterion 4). However, only one-quarter to one-third 
of the studies met these criteria. Criteria that were seldom fulfilled were “asking patients to 
give their own global rating for QoL” (criterion 5); distinguishing between overall QoL and 
health-related QoL” (criterion 6); “inviting patients to supplement the items that they 
considered to be relevant for their QoL” (criterion 7); and “allowing patients to indicate which 
items were important to them” (criterion 9). Hence, to achieve a better caliber of QoL studies 
in congenital heart disease, substantial improvement must occur. 
We also investigated temporal trends in the measurement methods employed. In this 
respect, we noted remarkable evolution. Thirty to 40 years ago, researchers only used 
surrogates of QoL, such as employment status, educational level, or NYHA class. By contrast, 
contemporary studies mainly use dedicated QoL instruments. Furthermore, the number of 
articles that did not specify the assessment method decreased dramatically, from 15.4% in 
1974-1994 to 3.6% in 2005-2014. This indicates a trend toward a more professional approach 
to conducting QoL research. This was further corroborated by the observation that 
increasingly more studies are describing QoL in the methods and results sections, instead of 
11 
 
drawing conclusions about QoL when it was not really even measured. Indeed, the proportion 
of studies that failed to describe QoL in the methods or results section decreased from 61.5% 
in 1974-1994 to 11.4% in 2005-2014. 
We hypothesized that the papers of Gill and Feinstein [4] and Moons et al. [7] 
prompted researchers to conduct and report their QoL studies more accurately. Although only 
a minority of articles reviewed here cited one or both of these papers, it is likely they still had 
a positive impact. Indeed, the articles that did cite these papers had higher quality scores than 
the articles that did not cite these papers. Hence, it is reasonable to infer that these researchers 
learned from these papers. Therefore, the scientific community, including authors, reviewers 
and editors, should give more attention to conceptual and methodological QoL papers, 
because they may substantially advance the caliber of QoL studies. 
On the basis of the Gill and Feinstein criteria [4] and the findings of the present 
review, we can propose some recommendations for future QoL research [9]. Following these 
recommendations would improve the conceptual and methodological rigor of QoL research 
and expand the knowledge base in this important field of research. 
1. Authors are required to provide the definition of QoL they used in their study. This is 
imperative to make sure that readers understand what the authors mean by the term QoL. 
In addition, it allows reviewers and readers to check whether QoL is inappropriately 
interchanged with other related concepts, such as health status, for example [9]. 
2. Authors are required to explicitly state the domains they measured as components of 
QoL, since QoL is considered to be a multidimensional or multifactorial construct. The 
choice of assessment instrument relies on the components included [9]. 
3. Authors should give the reason(s) for choosing the instruments they used. Valid 
assessments require that the instruments employed are suitable for the intended task. This 
ensures that QoL is measured appropriately according to the intended goals [9].  
4. Authors are required to state whether they measured overall QoL or health-related QoL. 
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A clear distinction between overall and health-related QoL should be expressed clearly in 
QoL papers [9]. 
5. Authors are required to explicitly state the indicators and determinants of QoL they 
measured in their study. Investigators need to stipulate how they measured QoL 
(indicators) and how they assessed influencing factors (determinants). Hence, making a 
clear distinction between indicators and determinants of QoL is imperative [9] . 
 
The results of the present review should be interpreted in light of some 
methodological issues. The strengths of this review are that we searched three widely used 
databases comprising biomedical research (PubMed, Cinahl, and Embase); the search, 
selection process, and review were independently done by two investigators; and all QoL 
studies published since 1974 were eligible for inclusion. Hence, we report on 40 years of QoL 
research in congenital heart disease. However, some methodological limitations need to be 
addressed as well. First, we used the 10 criteria developed by Gill and Feinstein [4]. To the 
best of our knowledge, no other list of criteria for assessing the quality of QoL studies is 
available. If such a list were to exist, it could lead to different results. Second, some of the 
improvements in quality may have remained “under the radar”; in other words, undetectable 
using our evaluation methods. Indeed, we acknowledge that some studies that normally would 
have used the term QoL, alternatively, now have used the term subjective health status or 
perceived functional status. Hence, the impact of the Gill and Feinstein paper [4] and the 
Moons et al. paper [7] may be larger than we were able to demonstrate using our approach. 
Third, the analyses in our review were made at the article level, not at the study or project 
level. We recognize that some studies or research projects have led to multiple articles. Thus, 
results of projects may be overrepresented when they originated from research groups that are 
highly productive in terms of publications. However, we did not have project-level data 
available for analysis.  
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5. Conclusions 
QoL research in congenital heart disease started some 40 years ago. Since then, numerous 
QoL studies in this area have been published. The caliber of these studies, however, was 
unknown up to the present date. Therefore, we were prompted to review all empirical studies 
published over the past 40 years in order to describe their characteristics in terms of quality 
and to determine whether temporal trends in conceptual and methodological rigor occurred 
with increasing experience in this field. We found slight but non-significant temporal 
improvements in conceptual and methodological rigor and in assessment methods. This 
indicates a trend toward a more professional approach in conducting and reporting QoL 
research. Furthermore, we observed that citation of the publications of Gill and Feinstein [4] 
and Moons et al. [7] in published QoL research is associated with higher quality scores, 
suggesting that these articles have a positive impact on conceptual and methodological 
caliber. However, we also determined that major weaknesses in methodological rigor remain 
present in published QoL research, and the majority of articles have substantial 
methodological problems. Hence, there is extensive room for improvements. We conclude 
that the scientific community should give more attention to conceptual and methodological 
papers dealing with QoL, because they may substantially advance the caliber of QoL studies. 
When planning future QoL studies, researchers should take the proposed requirements of this 
review into consideration.   
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Table 1 Evaluation of Conceptual and Methodological Rigor Over Three Epochs According to Predefined Criteria 
 
Criterion 
 
Gill and 
Feinstein [4] 
1974-1994 
(n=13) 
1995-2004 
(n=55) 
2005-2014 
(n=166) 
Chi² 
(p-value) 
1. Did the investigators give a definition of quality of life? 
 
11/75 (15%) 0/13 (0%) 8/55 (15%) 45/166 (27%) 7.75 (.02) 
2. Did the investigators state the domains they will measure as components of 
quality of life?  
 
35/75 (47%) 2/13 (15%) 17/55 (31%) 44/166 (27%) 1.34 (.51) 
3. Did the investigators give reasons for choosing the instruments they used?  
 
27/75 (36%) 0/13 (0%) 6/55 (11%) 38/166 (23%) 7.07 (.03) 
4. Did the investigators aggregate results from multiple items, domains, or 
instruments into a single composite score for quality of life?  
 
27/71 (38%) 1/10 (10%) 8/46 (17%) 53/157 (34%) 6.48 (.04) 
5. Were patients asked to give their own global rating for quality of life?  
 
13/75 (17%) 0/13 (0%) 2/55 (4%) 15/166 (9%) 2.87 (.24) 
6. Was overall quality of life distinguished from health-related quality of life?  
 
0/75 (0%) 0/13 (0%) 0/55 (0%) 9/166 (5%) 3.83 (.15) 
7. Were patients invited to supplement the items listed in the instruments 
offered by the investigators that they considered relevant for their quality 
of life?  
 
9/71 (13%) 0/9 (0%) 1/43 (2%) 2/157 (1%) 0.40 (.82) 
8. If so, were these supplemental items incorporated into the final rating?  
 
8/9 (89%) 0/0 (0%) 1/1 (100%) 2/2 (100%) NC 
9. Were patients allowed to indicate which items were personally important 
to them?  
 
6/71 (8.5%) 0/9 (0%) 1/43 (2%) 2/157 (1%) 0.40 (.82) 
10. If so, were the importance ratings incorporated into the final rating?  
 
3/6 (50%) 0/0 (0%) 1/1 (100%) 2/2 (100%) NC 
NC: Not computable. Bolded Chi2 values indicate significant difference. 
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Table 2 Quality of Life Assessments Used in the Different Time Periods 
1974-1994 1995-2004 2005-2014 
Instrument No. of 
studies 
(%) 
(n=13) 
Instrument No. of 
studies 
(%) 
(n=55) 
Instrument No. of 
studies 
(%) 
(n=166) 
Employment 5 (38.5) NYHA functional class 11 (20) SF-36 57 (34.3) 
NYHA functional class 3 (23.1) SF-36 5 (9.1) PedsQL 25 (15.1) 
Education 3 (23.1) CHD-TAAQOL 5 (9.1) Linear Analog Scale 14 (8.4) 
Symptoms 3 (23.1) Symptoms 5 (9.1) CHD-TAAQOL 11 (6.6) 
Perceived health status (1 item) 2 (15.4) Pregnancies and childbearing ability 4 (7.3) WHOQOL-BREF 9 (5.4) 
Marital state 2 (15.4) Employment 4 (7.3) Satisfaction with Life Scale 9 (5.4) 
Pregnancies and childbearing ability 1 (7.7) Protocol of Kajandi/Lindstrom 4 (7.3) Child Health Questionnaire 7 (4.2) 
Sport and recreation 1 (7.7) Perceived health status (1 item) 3 (5.5) TACQOL 6 (3.6) 
Insurance 1 (7.7) Marital state 3 (5.5) Pediatric Cardiac QOL Inventory 4 (2.4) 
Active life 1 (7.7) Education 3 (5.5) SF-12 4 (2.4) 
Normal unrestricted life 1 (7.7) Linear Analog Scale 2 (3.6) KINDL 3 (1.8) 
Functional status 1 (7.7) Child Health Questionnaire 2 (3.6) Employment 2 (1.2) 
Not reported 2 (15.4) Ability index 2 (3.6) Education 2 (1.2) 
  Resumption of work 2 (3.6) Ability index 2 (1.2) 
  Medication intake 2 (3.6) MLHFQ 2 (1.2) 
  Exercise capacity 2 (3.6) Camphor 2 (1.2) 
  Sport and recreation 1 (1.8) Kidscreen 2 (1.2) 
  Pain 1 (1.8) EQ-5D 2 (1.2) 
  Sickness Impact Profile 1 (1.8) Ulm Inventory for Children 2 (1.2) 
  TACQOL 1 (1.8) Physical Activity Questionnaire 2 (1.2) 
  Satisfaction with Life Scale 1 (1.8) Sport and recreation 1 (0.6) 
  SEIQOL 1 (1.8) NYHA functional class 1 (0.6) 
  Insurance 1 (1.8) Marital state 1 (0.6) 
  Possession of a driver’s license 1 (1.8) Protocol of Kajandi/Lindstrom 1 (0.6) 
  6-minute walk test 1 (1.8) Resumption of work 1 (0.6) 
  Neurological functioning 1 (1.8) Sickness Impact Profile 1 (0.6) 
  Physical fitness 1 (1.8) Pain 1 (0.6) 
  Need for reoperation 1 (1.8) SF-10 1 (0.6) 
17 
 
  Active life 1 (1.8) Early Childhood Oral Health Impact 
Scale 
1 (0.6) 
  Health Utility Index 1 (1.8) MIDAS 1 (0.6) 
  Psychological profile 1 (1.8) Hopkins Symptoms Checklist 1 (0.6) 
  IQLC 1 (1.8) Family Assessment Device 1 (0.6) 
  Quality of life questionnaire for 
chronic lung disease 
1 (1.8) Spanier Dyadic Adjustment Scale 1 (0.6) 
  Duke questionnaire 1 (1.8) Physical Self-Perception Profile 1 (0.6) 
  Limitations to activity 1 (1.8) ConQol 1 (0.6) 
  Not reported 10 (18.2) LQ-KID 1 (0.6) 
    SEIQOL 1 (0.6) 
    TAPQOL 1 (0.6) 
    Not reported 6 (3.6) 
NYHA, New York Heart Association; SF-36, Medical Outcome Study Short Form-36; CHD-TAAQOL, Congenital Heart Disease TNO/AZL Adult Quality of Life; 
TACQOL, TNO/AZL Children’s Quality of Life; SEIQOL, Schedule for the Evaluation of Individual Quality of Life; IQLC, Inventory for the Assessment of the Quality of 
Life in Children and Adolescents; PedsQL, Pediatric Quality of Life Inventory; WHOQOL-BREF, World Health Organization Quality Of Life – Abbreviated version; 
TACQOL, TNO/AZL Children’s Quality of Life; SF-12, Medical Outcome Study Short Form-12; KINDL, Fragebogen für KINDer und Jugendliche zur Erfassung der 
gesundheitsbezogenen Lebensqualität; MLHFQ, Minnesota Living with Heart Failure Questionnaire; Camphor, Cambridge Pulmonary Hypertension Outcome Review; EQ-
5D, EuroQol-5 dimensions; SF-10, Medical Outcome Study Short Form-10; MIDAS, Migraine Disability Assessment; ConQol, Congenital Heart Disease Quality of Life 
Questionnaire; LQ-KID, Fragebogen zur Lebensqualität bei Kindern und Jugendlichen; TAPQOL, TNO/AZL Preschool children’s Quality of Life 
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Figure Legend 
 
Figure 1 Number of Articles on Quality of Life in Patients with Congenital Heart Disease 
Published per Year 
 
Figure 2 Heart Defects of Subjects in Quality of Life Studies 
 
Figure 3 Temporal Trends in Conceptual and Methodological Rigor of Quality-of-Life 
Studies in Patients with Congenital Heart Disease 
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Figure 1 Number of Articles on Quality of Life in Patients with Congenital Heart Disease 
Published per Year 
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Figure 2 Heart Defects of Subjects in Quality of Life Studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DORV, double outlet right ventricle; ASD, atrial septal defect; PFO, patent foramen ovale; VSD, ventricular 
septal defect;  
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Figure 3 Temporal Trends in Conceptual and Methodological Rigor of Quality-of-Life 
Studies in Patients with Congenital Heart Disease 
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Appendix 1: Search strings employed in the three literature databases. 
PubMed 
(("quality of life"[All Fields] OR "life quality"[All Fields]) AND ("congenital heart"[All Fields] OR 
"congenital cardiac"[All Fields] OR "heart defects"[All Fields] OR Fallot[All Fields] OR 
("transposition"[All Fields] AND "great arteries"[All Fields]) OR ("aortic coarctation"[MeSH 
Terms] OR ("aortic"[All Fields] AND "coarctation"[All Fields]) OR "aortic coarctation"[All Fields] 
OR "coarctation"[All Fields]) OR Eisenmenger[All Fields] OR "septal defect"[All Fields] OR 
"septal-defects"[All Fields] OR "atrial septal defect"[All Fields] OR "ventricular septal defect"[All 
Fields] OR "congenital aortic stenosis"[All Fields] OR "congenital pulmonary stenosis"[All Fields] 
OR univentricular[All Fields] OR "single ventricle"[All Fields] OR "hypoplastic left heart"[All 
Fields] OR "tricuspid atresia"[All Fields] OR "pulmonary atresia"[All Fields] OR "anomalous 
pulmonary venous"[All Fields] OR "truncus arteriosus"[All Fields] OR "ductus arteriosus"[All 
Fields] OR Fontan[All Fields] OR Marfan[All Fields] OR "double outlet"[All Fields] OR "double 
inlet"[All Fields] OR Ebstein[All Fields] OR “anomalous aortic”[All Fields] OR “anomalous 
coronary”[All Fields] OR “interrupted aortic”[All Fields] OR "congenital aortic valve"[All Fields] 
OR "congenital pulmonary valve"[All Fields])) AND ("1900/01/01"[PDAT] : 
"2014/12/31"[PDAT]) AND English[lang] NOT (Editorial[ptyp] OR Letter[ptyp] OR Case 
Reports[ptyp] OR Review[ptyp]) 
 
Embase 
((('quality of life'/exp OR 'quality of life' OR 'life quality'/exp OR 'life quality') AND ('congenital 
heart disease'/exp OR 'congenital heart' OR 'congenital cardiac' OR heart NEAR/1 defect* OR 
‘fallot’ OR transposition NEAR/1 “great arteries” OR aort* NEAR/1 coarct* OR eisenmenger OR 
septal NEAR/2 defect* OR congenit* NEAR/2 stenos* OR aort* AND near AND stenos* OR 
univentricul* OR 'single ventricle' OR 'hypoplastic left heart' OR (tricuspid OR pulmonar*) 
NEAR/1 atresia OR 'pulmonary vein malformation'/exp OR (anomalous AND pulmonary NEAR/1 
(vein* OR venous)) OR (ductus OR truncus) NEAR/1 arteriosus OR fontan OR marfan OR double 
NEAR/1 (inlet* OR outlet*) OR ebstein OR anomalous NEAR/1 (aort* OR coronar*) OR 
interrupt* NEAR/1 aort* OR congenital NEAR/2 valve*)) NOT (‘conference abstract’/it OR 
‘editorial’/it OR 'letter'/it OR 'note'/it OR 'review'/it OR 'case report'/de OR ‘erratum’/it OR 
‘conference review’/it)) AND [english]/lim 
 
Cinahl 
(MH "Quality of Life") OR 'quality of life' OR 'life quality') 
AND 
((MH "Heart Defects, Congenital+") OR 'congenital heart' OR ‘congenital cardiac’ OR (heart N1 
defect*) OR Fallot OR (transposition N1 ‘great arteries’) OR (MH "Aortic Coarctation") OR (aort* 
N1 coarct*) OR eisenmenger OR septal N2 defect* OR (congenit* N2 stenos*) OR (aort* N1 
stenos*) OR univentricul* OR ‘single ventricle’ OR ‘hypoplastic left heart’ OR (tricuspid OR 
pulmonar*) N1 atresia OR (anomalous AND (pulmonary N1 (vein* OR venous))) OR ((ductus OR 
truncus) N1 arteriosus OR Fontan OR Marfan OR (double N1 (inlet* OR outlet*)) OR Ebstein OR 
(anomalous N1 (aort* OR coronar*)) OR (interrupt* N1 aort*) OR (congenital N2 valve*))  
NOT  
(letter OR editorial OR review OR case study OR Doctoral Dissertations OR CEU) [PT Publication 
Type] 
LIMITERS 
English language [LA Language] 
 
Appendix 2: Flow diagram of article selection 
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Records identified through 
Cinahl search 
(n=172) 
 
Records after duplicates removed 
(n=769) 
Records screened  
(n=769) 
Records excluded (n = 535) using following exclusion 
hierarchy: 
1. PhD thesis (n=6) 
2. conference abstract or proceeding (n=7) 
3. non-English (n=1) 
4. non-human research (n=11) 
5. not structural/congenital heart defect (e.g., rheumatic 
heart disease, cardiomyopathies, acquired heart 
disease, primary pulmonal hypertension or 
syndromes) (n=186) 
6. transplant-related issues (incl. bridging to transplant) 
(n=37) 
7. letter to the editor/invited commentary (n=3) 
8. editorial (n=7) 
9. opinion article, scientific statement, process of care 
report, methods paper, research agenda (n=89) 
10. case study (n=3) 
11. review article (n=32) 
12. qualitative study (n=16) 
13. study on parents, siblings or relatives; or on 
professionals (n=18) 
14. study on fetus (n=1) 
15. QoL not mentioned in title, or methods, results, or 
conclusion of abstract (n=118) 
Studies reviewed 
(n=234) 
Records identified through 
Embase search 
(n=263) 
 
 
Appendix 3: Review criteria developed by Gill and Feinstein [1] and refined by Moons et al. [2] 
 
1. Did the investigators give a definition of quality of life? 
Because a uniform definition of quality of life presently does not exist, investigators need to clarify 
their conceptualization of quality of life to ensure that readers have a good understanding of the term, 
as they define it. Therefore, investigators must provide an explicit definition of quality of life that 
serves as a basis for selecting the instruments to be used in their study. Simply referring to the wide 
variety of definitions, describing the components of quality of life, or citing multiple definitions 
without unequivocally quoting the definition underpinning the measurement is inadequate. 
 
2. Did the investigators state the domains they will measure as components of quality of life?  
Quality of life is typically considered to be a multidimensional construct, comprising multiple 
domains. The choice of quality-of-life instrument(s) basically relies on the components included in the 
instrument(s). To determine whether the selected measurement appropriately represents the desired 
target domain, investigators ought to stipulate explicitly which domains they consider to be significant 
constituents of quality of life. Just describing domains underlying a specific questionnaire is not 
sufficient. 
 
3. Did the investigators give reasons for choosing the instruments they used?  
Valid assessments require that the instruments used are suitable for the intended task. Since numerous 
quality-of-life instruments exist, investigators need to state their reasons for choosing to use a 
particular instrument or instruments to assess quality of life. These reasons should ensure that quality 
of life will be measured appropriately according to their intended goals. Just because an instrument has 
good psychometric properties or is widely used does not mean suitable reasons were considered for its 
use. 
 
4. Did the investigators aggregate results from multiple items, domains, or instruments into a 
single composite score for quality of life?  
It is reasonable to conclude that an effective characterization of quality of life is enhanced if 
investigators present a composite score that summarizes the results of multiple items, domains, or 
instruments. Although the richness of a profile description may be lost, an aggregated score simplifies 
the communication of results and permits the assessment of interrelationships between quality of life 
and other variables. 
 
5. Were patients asked to give their own global rating for quality of life?  
Although quality of life is principally conceptualized as a multidimensional construct, a single global 
rating by the patient is useful. Patients’ rating of their quality of life on a 1-item scale reflects the 
disparate values and preferences of individual patients. Hence, such a rating serves as an overall 
estimate of quality of life that considers quality-of-life components deemed important by the 
respondent. 
 
6. Was overall quality of life distinguished from health-related quality of life?  
Health-care professionals are predominantly interested in health-related factors to be components of 
patients’ quality of life. However, a holistic approach implies that also nonmedical phenomena emerge 
as being important, such as family relationships, social networks, spirituality, pet ownership, etc. 
Consequently, a distinction between overall and health-related quality of life should be made clear in 
quality-of-life articles. In this review, we considered this criterion to be fulfilled if the authors 
explicitly stated the difference between overall and health-related quality of life. 
 
7. Were patients invited to supplement the items listed in the instruments offered by the 
investigators that they considered relevant for their quality of life?  
Since there is a growing awareness that quality of life can only be affected by components that are 
important for an individual, an adequate measurement of quality of life should provide the possibility 
for respondents to indicate the domains that they judge to be important for their quality of life. Some 
argue that this approach is the only way that can lead to a valid measurement of quality of life, because 
 
 
it explicitly includes the domains that are relevant for respondents.  
 
8. If item 7 was satisfied in the research, were these supplemental items provided by the 
respondent incorporated into the final rating?  
To take the supplemental items into consideration in the assessment of quality of life, they ought to be 
incorporated into the final rating. If there is no possibility of obtaining supplemental items, this 
criterion is not applicable. 
 
9. Were patients allowed to indicate which items were personally important to them?  
Patients need to have the opportunity to rate the importance of different items, either those specified 
by the investigators or those added by the patients. This offers the possibility to individually weigh the 
items and guards against the assumption that all items have the same importance for all patients. 
 
10. If item 9 was satisfied in the research, were the importance ratings incorporated into the 
final rating?  
As for the case of the supplemental items in review criterion 7, the importance rating should be 
incorporated into the final rating. Again, if there is no possibility of scoring the importance of different 
items, this criterion is not applicable. 
 
 
 
Reproduced with kind permission of American Medical Association. Moons P, Van Deyk K, Budts W, 
De Geest S. Caliber of quality-of-life studies in congenital heart disease: A plea for more conceptual 
and methodological rigor. Archives of Pediatrics & Adolescent Medicine 2004; 158: 1062-1069. 
Copyright © (2004) American Medical Association. All rights reserved. 
 
  
 
 
Appendix 4. Countries where the studies were performed 
 
 
 
 
  
 
 
Appendix 5: Caliber of quality of life studies in congenital heart disease 
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1975 Taussig[3] 0 0 0 0 0 0 0 n/a 0 n/a 0 
1977 Hallidie-Smith [4] 0 0 0 0 0 0 0 n/a 0 n/a 0 
1981 Arciniegas [5] 0 0 0 0 0 0 0 n/a 0 n/a 0 
1984 Raj-Behl [6] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Vergesslich [7] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
1985 Ishizawa [8] 0 0 0 0 0 0 0 n/a 0 n/a 0 
1990 Lozano[9] 0 0 0 1 0 0 n/a n/a n/a n/a 0 
1993 Gersony[10] 0 1 0 0 0 0 0 n/a 0 n/a 13 
 Miyamura [11] 0 0 0 0 0 0 0 n/a 0 n/a 0 
1994 Casey [12] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Kuribayashi [13] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Meijboom [14] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Park [15] 0 1 0 0 0 0 0 n/a 0 n/a 13 
1995 Benatar [16] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Meijboom [17] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
1996 Meijboom [18] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Miyamura [19] 0 1 0 0 0 0 0 n/a 0 n/a 13 
 Shibata [20] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Shyamkrishnan [21] 0 0 0 0 0 0 n/a n/a n/a n/a 0 
1997 Elkins [22] 0 0 0 0 0 0 n/a n/a n/a n/a 0 
 Moyen Laane [23] 0 1 0 1 0 0 0 n/a 0 n/a 25 
 Moyen Laane [24] 0 1 0 1 0 0 0 n/a 0 n/a 25 
 Schreiber [25] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
1998 Belli E [26] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Daliento [27] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Wilson [28] 0 0 0 0 0 0 0 n/a 0 n/a 0 
1999 Belli [29] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Breymann [30] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Dittrich [31] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Kupilik [32] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Rosenzweig [33] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2000 Aeba [34] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Haas [35] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Hucin [36] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Leonard [37] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Mahle [38] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Williams [39] 0 1 0 0 0 0 0 n/a 0 n/a 13 
2001 Fekkes [40] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Mair [41] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 
 
 Saliba [42] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Sandoval [43] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Sugimoto [44] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Ternestedt [45] 0 1 0 0 0 0 0 n/a 0 n/a 13 
 Yozu [46] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2002 Hovels-Gurich [47] 0 1 0 0 0 0 0 n/a 0 n/a 13 
 Kamphuis [48] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Kamphuis [49] 1 0 0 0 0 0 0 n/a 0 n/a 13 
 Lane [50] 0 1 0 0 0 0 0 n/a 0 n/a 13 
 Mair [51] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Rietveld [52] 0 1 0 0 0 0 0 n/a 0 n/a 13 
 Walker [53] 0 1 0 0 0 0 0 n/a 0 n/a 13 
 Yamashita [54] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2003 Burkhart [55] 0 0 0 1 0 0 n/a n/a n/a n/a 17 
 Carriço [56] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Culbert [57] 0 1 1 0 0 0 0 n/a 0 n/a 25 
 Dearani [58] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Krol [59] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Simko [60] 1 1 0 1 0 0 0 n/a 0 n/a 38 
2004 Burkhart [61] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 De Giovanni [62] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Ekman-Joelsson [63] 1 1 1 1 0 0 0 n/a 0 n/a 50 
 Jefferies [64] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Kamphuis [65] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Moons [66] 1 1 0 1 1 0 1 1 1 1 80 
 Moons [67] 1 1 1 0 1 0 0 n/a 0 n/a 50 
 Morgan [68] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Stephensen [69] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 van den Bosch [70] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2005 Daliento [71] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Dos [72] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Goldbeck [73] 1 1 0 1 0 0 0 n/a 0 n/a 38 
 Hager [74] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Immer [75] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Irtel [76] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Moons [77] 1 1 1 1 1 1 1 1 1 1 100 
 Moons [78] 1 1 0 1 0 1 1 1 1 1 80 
 Rose [79] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Sairanen [80] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Simko [81] 1 1 1 1 0 0 0 n/a 0 n/a 50 
2006 Andersen [82] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Boston [83] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Goldbeck [84] 1 1 1 1 0 0 0 n/a 0 n/a 50 
 Ibrahim [85] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Macran [86] 0 1 1 1 0 0 0 n/a 0 n/a 38 
 Majnemer [87] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Moons [88] 1 1 1 1 1 0 0 n/a 0 n/a 63 
 Reiss [89] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Schmid [90] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Spijkerboer [91] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Stulak [92] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 
 
2007 Bisoi [93] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Bol Raap [94] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Brosig [95] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Bruto [96] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Ebenroth [97] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Hövels-Gürich [98] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Kimmelstiel [99] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Mellander [100] 1 1 1 1 0 0 0 n/a 0 n/a 50 
2008 de Koning [101] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Hoffmann [102] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Karsdorp [103] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Landolt [104] 1 1 1 1 0 0 0 n/a 0 n/a 50 
 Li [105] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Marino [106] 0 0 1 1 0 0 0 n/a 0 n/a 25 
 Pilla [107] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Simons [108] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Winter [109] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2009 Brothers [110] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 da Fonseca [111] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 d'Udekem [112] 0 0 1 0 0 0 0 n/a 0 n/a 13 
 Duffels [113] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Duffels [114] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Gratz [115] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Loup [116] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Moons [117] 1 1 1 1 1 0 n/a n/a n/a n/a 83 
 Müller [118] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Ovaert [119] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Vandekerckhove [120] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Vigl [121] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2010 Berkes [122] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Bouallal [123] 0 0 0 0 0 0 n/a n/a n/a n/a 0 
 Cohen [124] 1 1 0 0 0 0 0 n/a 0 n/a 25 
 Dua [125] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Khan [126] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Lei [127] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Lu [128] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Martinez-Quintana [129] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Tahirovic [130] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Winter [131] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2011 Backer [132] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Chen [133] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Friesen [134] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Gaies [135] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Gierat-Haponiuk [136] 0 0 0 1 1 0 0 n/a 0 n/a 25 
 Goldbeck [137] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Görler [138] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Hanninen [139] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Kwon [140] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Lemmer [141] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Luyckx [142] 1 1 1 1 1 0 n/a n/a n/a n/a 83 
 Luyckx [143] 1 1 1 1 1 0 n/a n/a n/a n/a 83 
 
 
 Ma [144] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Mokhles [145] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Müller [146] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Müller [147] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Neuner [148] 1 1 1 1 0 0 0 n/a 0 n/a 50 
 Overgaard [149] 1 1 1 1 1 0 0 n/a 0 n/a 63 
 Silva [150] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Tahirovic [151] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Tay [152] 1 0 0 1 0 1 0 n/a 0 n/a 38 
 Tay [153] 1 0 0 1 0 1 0 n/a 0 n/a 38 
 Teixeira [154] 0 1 1 1 0 1 0 n/a 0 n/a 50 
 Vigl [155] 1 1 1 0 0 1 0 n/a 0 n/a 50 
 Yurlov [156] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2012 Angeli [157] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Bygstad [158] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Costello [159] 1 1 0 0 0 0 0 n/a 0 n/a 25 
 Cotts [160] 1 1 1 1 1 0 0 n/a 0 n/a 63 
 Czosek [161] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Ehlert [162] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Huang [163] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Knowles [164] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Lu [165] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Luyckx [166] 1 1 1 1 1 0 n/a n/a n/a n/a 83 
 Müller [167] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Müller [168] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Opic [169] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Pike [170] 1 1 1 1 0 1 0 n/a 0 n/a 63 
 Riley [171] 1 1 0 0 0 0 0 n/a 0 n/a 25 
 Schoormans [172] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Sharma [173] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Winter [174] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2013 Apers [175] 1 1 1 1 1 0 n/a n/a n/a n/a 83 
 Atz [176] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Bang [177] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Becker-Grünig [178] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Bolio-Cerdan [179] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Cha [180] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Cuypers [181] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Eagleson [182] 1 1 1 1 0 1 0 n/a 0 n/a 63 
 Eslami [183] 1 1 1 0 1 0 0 n/a 0 n/a 50 
 Garcia Guerra [184] 1 1 1 1 0 0 0 n/a 0 n/a 50 
 Heiberg [185] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Idorn [186] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Kahya Eren [187] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Lakhdhar [188] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Lu [189] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Mueller [190] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Müller [191] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Müller [192] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Müller [193] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 O'Byrne [194] 1 1 1 1 0 0 0 n/a 0 n/a 50 
 
 
 Rassart [195] 1 1 1 0 1 0 n/a n/a n/a n/a 67 
 Ruys [196] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Sandberg [197] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Schaefer [198] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Schuuring [199] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Uzark [200] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 van der Bom [201] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Vis [202] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Younge [203] 0 0 0 0 0 0 0 n/a 0 n/a 0 
2014 Areias [204] 1 0 0 1 0 0 0 n/a 0 n/a 25 
 Bedair [205] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Bertoletti [206] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Brosig [207] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Dean [208] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Dulfer [209] 0 0 0 0 1 0 0 n/a 0 n/a 13 
 Dulfer [210] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Frigiola [211] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Garcia-Guerra [212] 1 1 1 1 0 0 0 n/a 0 n/a 50 
 Gerelli [213] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Goldberg [214] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Hebert [215] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Heusch [216] 1 0 0 1 0 0 0 n/a 0 n/a 25 
 Knowles [217] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Komar [218] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Komar [219] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Luyckx [220] 1 1 1 1 1 0 n/a n/a n/a n/a 83 
 Ly [221] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Mellion [222] 1 1 1 1 0 0 0 n/a 0 n/a 50 
 Müller [223] 0 1 1 0 0 1 0 n/a 0 n/a 38 
 Mussatto [224] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 O'Byrne [225] 1 0 0 1 0 0 0 n/a 0 n/a 25 
 Opic [226] 0 0 0 1 0 0 0 n/a 0 n/a 13 
 Opic[227] 0 0 0 0 1 0 0 n/a 0 n/a 13 
 Raju [228] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Schoormans [229] 1 1 0 0 0 0 0 n/a 0 n/a 25 
 Schoormans [230] 1 1 1 0 0 0 0 n/a 0 n/a 38 
 Sistino [231] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 Wang [232] 0 1 0 1 0 0 0 n/a 0 n/a 25 
 Werner [233] 1 1 0 1 0 0 0 n/a 0 n/a 38 
 Wittlieb-Weber [234] 0 0 0 1 0 0 0 n/a 0 n/a 13 
2015 Neal [235] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 van der Bom [236] 0 0 0 0 0 0 0 n/a 0 n/a 0 
 
 * 1974-1994 1995-2003 2004- 2014 
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